Literature DB >> 8186663

Myofibrillogenesis in primary tissue cultures of adult human skeletal muscle: expression of desmin, titin, and nebulin.

T Behr1, P Fischer, W Müller-Felber, M Schmidt-Achert, D Pongratz.   

Abstract

To investigate the in vitro development of myofibrils in skeletal muscle cells derived from adult human muscle biopsies, immunohistochemical analysis was performed using monoclonal antibodies against desmin, titin, and nebulin. Diffuse desmin reactivity was detected 48 h after plating in about 60% of all mononucleated cells. This supports the use of desmin as a marker for undifferentiated rhabdomyosarcomas in man. Titin was visible from day 4 onwards, while nebulin was not found in mononucleated cells. After 1 week polynucleated myotubes appeared, and grew up to 30 days. Desmin was distributed diffusely throughout the cytoplasm until day 21, when the pattern became patchy. Titin began to be organized in a predominantly longitudinal orientation at day 15, while nebulin, which appeared for the first time in fusing myoblasts on the fifth to the seventh day, was almost immediately organized in a dotted longitudinal pattern, which became a Z line connected striation in matured myotubes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8186663     DOI: 10.1007/bf00184594

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  23 in total

1.  The organization of titin (connectin) and nebulin in the sarcomeres: an immunocytolocalization study.

Authors:  S Pierobon-Bormioli; R Betto; G Salviati
Journal:  J Muscle Res Cell Motil       Date:  1989-12       Impact factor: 2.698

2.  A new program for investigating adult human skeletal muscle grown aneurally in tissue culture.

Authors:  V Askanas; W K Engel
Journal:  Neurology       Date:  1975-01       Impact factor: 9.910

3.  The distribution of intermediate filament protein (skeletin) in normal and diseased human skeletal muscle--an immunohistochemical and electron-microscopic study.

Authors:  L E Thornell; L Edström; A Eriksson; K G Henriksson; K A Angqvist
Journal:  J Neurol Sci       Date:  1980-08       Impact factor: 3.181

4.  Interaction of alpha-actinin and nebulin in vitro. Support for the existence of a fourth filament system in skeletal muscle.

Authors:  R Nave; D O Fürst; K Weber
Journal:  FEBS Lett       Date:  1990-08-20       Impact factor: 4.124

5.  Connectin, an elastic protein from myofibrils.

Authors:  K Maruyama
Journal:  J Biochem       Date:  1976-08       Impact factor: 3.387

6.  Behaviour of connectin (titin) and nebulin in skinned muscle fibres released after extreme stretch as revealed by immunoelectron microscopy.

Authors:  K Maruyama; A Matsuno; H Higuchi; S Shimaoka; S Kimura; T Shimizu
Journal:  J Muscle Res Cell Motil       Date:  1989-10       Impact factor: 2.698

7.  Architecture of the sarcomere matrix of skeletal muscle: immunoelectron microscopic evidence that suggests a set of parallel inextensible nebulin filaments anchored at the Z line.

Authors:  K Wang; J Wright
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

8.  Myogenesis in the mouse embryo: differential onset of expression of myogenic proteins and the involvement of titin in myofibril assembly.

Authors:  D O Fürst; M Osborn; K Weber
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

9.  The organization of titin filaments in the half-sarcomere revealed by monoclonal antibodies in immunoelectron microscopy: a map of ten nonrepetitive epitopes starting at the Z line extends close to the M line.

Authors:  D O Fürst; M Osborn; R Nave; K Weber
Journal:  J Cell Biol       Date:  1988-05       Impact factor: 10.539

10.  Immunoelectron microscopic studies of desmin (skeletin) localization and intermediate filament organization in chicken cardiac muscle.

Authors:  K T Tokuyasu; A H Dutton; S J Singer
Journal:  J Cell Biol       Date:  1983-06       Impact factor: 10.539

View more
  7 in total

Review 1.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

2.  Autologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study.

Authors:  Sophie Périé; Capucine Trollet; Vincent Mouly; Valérie Vanneaux; Kamel Mamchaoui; Belaïd Bouazza; Jean Pierre Marolleau; Pascal Laforêt; Françoise Chapon; Bruno Eymard; Gillian Butler-Browne; Jérome Larghero; Jean Lacau St Guily
Journal:  Mol Ther       Date:  2013-07-08       Impact factor: 11.454

Review 3.  The identification of myogenic cells in skeletal muscle, with emphasis on the use of tritiated thymidine autoradiography and desmin antibodies.

Authors:  M J Lawson-Smith; J K McGeachie
Journal:  J Anat       Date:  1998-02       Impact factor: 2.610

4.  Neuronal Agrin Promotes Proliferation of Primary Human Myoblasts in an Age-Dependent Manner.

Authors:  Katarina Gros; Urška Matkovič; Giulia Parato; Katarina Miš; Elisa Luin; Annalisa Bernareggi; Marina Sciancalepore; Tomaž Marš; Paola Lorenzon; Sergej Pirkmajer
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

5.  The role of Pitx2 in maintaining the phenotype of myogenic precursor cells in the extraocular muscles.

Authors:  Sadie L Hebert; Mark L Daniel; Linda K McLoon
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

6.  Low Intensity Exercise Training Improves Skeletal Muscle Regeneration Potential.

Authors:  Tiziana Pietrangelo; Ester S Di Filippo; Rosa Mancinelli; Christian Doria; Alessio Rotini; Giorgio Fanò-Illic; Stefania Fulle
Journal:  Front Physiol       Date:  2015-12-24       Impact factor: 4.566

7.  Superoxide Anion Production and Bioenergetic Profile in Young and Elderly Human Primary Myoblasts.

Authors:  Mariangela Marrone; Rita Maria Laura La Rovere; Simone Guarnieri; Ester Sara Di Filippo; Giovanni Monaco; Tiziana Pietrangelo; Geert Bultynck; Stefania Fulle; Rosa Mancinelli
Journal:  Oxid Med Cell Longev       Date:  2018-07-24       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.